ENLV short interest
Enlivex Therapeutics Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 98,600 |
|---|---|
| Change vs prior report | 50,396 (+104.5%) |
| Change over six months | -81.6% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 611,232 |
| Rank in Healthcare | #779 of 922 by days to cover |
ENLV short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 98,600 | +104.5% | 1.00 | 611,232 |
| 2026-09-15 | 48,204 | -59.8% | 1.00 | 259,918 |
| 2026-08-31 | 119,854 | +15.0% | 1.00 | 265,621 |
| 2026-08-14 | 104,202 | -41.3% | 1.00 | 316,969 |
| 2026-07-31 | 177,544 | +571.2% | 1.00 | 466,302 |
| 2026-07-15 | 26,452 | -98.2% | 1.00 | 67,658 |
| 2026-06-30 | 1,511,367 | +336.3% | 4.02 | 376,254 |
| 2026-06-15 | 346,372 | -17.1% | 1.00 | 366,015 |
| 2026-05-29 | 417,769 | +2.5% | 1.00 | 461,626 |
| 2026-05-15 | 407,544 | -23.7% | 1.66 | 245,686 |
| 2026-04-30 | 534,224 | -2.0% | 1.13 | 473,446 |
| 2026-04-15 | 545,016 | +1.9% | 1.00 | 589,600 |
| 2026-03-31 | 535,106 | +3.7% | 1.00 | 1,214,010 |
| 2026-03-13 | 515,954 | -8.5% | 3.10 | 166,568 |
| 2026-02-27 | 563,947 | +8.1% | 2.95 | 191,306 |
| 2026-02-13 | 521,667 | -0.8% | 1.43 | 365,363 |
| 2026-01-30 | 526,156 | +160.9% | 1.09 | 481,087 |
| 2026-01-15 | 201,697 | -66.6% | 1.00 | 454,313 |
| 2025-12-31 | 603,238 | +158.4% | 1.05 | 573,162 |
| 2025-12-15 | 233,417 | -79.7% | 1.00 | 1,100,765 |
| 2025-11-28 | 1,147,847 | +573.6% | 1.00 | 23,566,297 |
| 2025-11-14 | 170,414 | +92.0% | 1.82 | 93,398 |
| 2025-10-31 | 88,743 | -48.8% | 1.00 | 148,957 |
| 2025-10-15 | 173,179 | -34.5% | 1.00 | 212,756 |
| 2025-09-30 | 264,402 | -14.8% | 1.81 | 145,864 |
import finzdata as yf
yf.Ticker("ENLV").short_interest # every report since 2017
yf.Client().short_interest(["ENLV"], start="2018-01-01")Healthcare short interest · ENLV price history · Who owns ENLV · All short interest